14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $133.39 $156.84 Friday, 3rd May 2024 ASND stock ended at $137.20. This is 2.76% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 5.33% from a day low at $135.16 to a day high of $142.36.
90 days $133.39 $161.00
52 weeks $83.75 $161.00

Historical Ascendis Pharma A/S prices

Date Open High Low Close Volume
Oct 02, 2020 $154.25 $159.57 $153.44 $158.63 164 244
Oct 01, 2020 $156.54 $158.07 $153.37 $156.00 148 970
Sep 30, 2020 $152.63 $155.80 $150.03 $154.32 468 363
Sep 29, 2020 $152.13 $154.05 $148.25 $152.26 277 442
Sep 28, 2020 $154.20 $154.72 $149.02 $151.94 207 692
Sep 25, 2020 $147.62 $154.23 $146.84 $154.03 258 726
Sep 24, 2020 $145.44 $149.22 $141.38 $149.22 193 899
Sep 23, 2020 $144.50 $147.39 $141.39 $146.00 512 035
Sep 22, 2020 $141.40 $144.53 $139.49 $144.27 108 993
Sep 21, 2020 $145.00 $145.88 $139.10 $140.70 132 249
Sep 18, 2020 $146.91 $147.88 $144.82 $147.00 101 309
Sep 17, 2020 $143.77 $147.07 $143.77 $145.71 155 616
Sep 16, 2020 $143.47 $145.33 $141.59 $145.03 153 909
Sep 15, 2020 $146.23 $147.61 $140.39 $142.50 222 724
Sep 14, 2020 $146.37 $148.06 $144.10 $146.99 158 179
Sep 11, 2020 $141.37 $144.99 $140.71 $144.70 114 604
Sep 10, 2020 $144.88 $145.65 $141.52 $142.75 112 407
Sep 09, 2020 $143.46 $147.19 $141.64 $144.22 125 521
Sep 08, 2020 $138.83 $144.60 $137.51 $143.13 145 823
Sep 04, 2020 $139.63 $143.28 $133.03 $140.34 214 550
Sep 03, 2020 $141.25 $141.78 $136.96 $139.77 174 141
Sep 02, 2020 $144.43 $145.96 $141.02 $141.81 88 895
Sep 01, 2020 $145.57 $147.33 $142.39 $144.06 198 057
Aug 31, 2020 $139.19 $150.21 $139.19 $148.18 240 289
Aug 28, 2020 $138.17 $139.17 $135.48 $139.15 151 281
Click to get the best stock tips daily for free!

About Ascendis Pharma A/S

Ascendis Pharma A/S Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT